B7-H3-induced Myeloid–Stromal Circuit Enables Combinatorial Immunotherapy in Advanced Prostate Cancer
Advanced prostate cancer remains largely refractory to immune-checkpoint blockade, highlighting the need to understand the cellular networks that sustain immune exclusion. In a recent study, Shi and colleagues identify tumor-cell B7-H3 as a key organizer of a myeloid–stromal circuit in prostate cancer. B7-H3 activates...